The Hertfordshire-based healthcare shop beat more established rivals to land the brief, which industry sources claim is worth a significant six-figure sum, for Galderma's cosmetic portfolio, following a competitive pitch. It includes promoting the firm's new botulinum toxin Azzalure.
The product, a competitor to Botox, which is produced by Allergan, was launched into the market last year.
Signature will spearhead the national PR and medical education activity for the skincare firm's cosmetic products.
The agency will be responsible for implementing a series of medical education and direct-to-consumer campaigns, including disease awareness and understanding, media and advocacy, plus data and congress support.
Signature was founded by former HSD Communications directors Siobhan Wastie and Cerys Evans two years ago (PRWeek, 29 May 2008). They left HSD just months after the agency was bought out by integrated comms agency Gyro International.
The agency has vast experience in the dermatology arena and currently works with the Primary Care Dermatology Society, as well as a number of pan-European dermatology companies.
Signature also won work with Galderma last year to promote its acne products (PRWeek, 20 March 2009).
The win follows Signature's appointment to handle a medical education campaign for eczema treatment Toctino following a competitive pitch earlier this month (PRWeek, 5 February).